Hemcheck Sweden AB (publ) (HEMC.ST)
Hemcheck Sweden AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Karlstad, SE. The stock last traded at $0.23, up 26.11% on the session, giving a market capitalisation of $8.6M. Its beta of 1.48 implies it has historically moved more than the broad market.
Hemcheck Sweden AB (publ) is a Swedish medical technology company. They specialize in developing and marketing Helge, a device capable of identifying hemolysis in blood samples at the point of care. The company's services are primarily aimed at emergency departments within the European Union and the United States. Hemcheck was founded in 2010 and is based in Karlstad, Sweden.
Hemcheck Sweden AB (publ) is most often compared with the following Healthcare names: